Same meningitis strain behind Drexel, Princeton outbreaks

March 18, 2014
Same meningitis strain behind drexel, princeton outbreaks: CDC
Drexel student recently died from the bacterial infection.

(HealthDay)—The strain of bacterial meningitis that killed a Drexel University student earlier this month is the same strain behind a Princeton University outbreak last year, federal health officials said Tuesday.

This suggests that the outbreak strain might still be present in the Princeton community and that the situation requires close monitoring, according to the U.S. Centers for Disease Control and Prevention.

After the Drexel student died March 10, the local health department identified people who had been in close contact with the student and gave them antibiotics to protect them from developing meningitis. So far, no further cases of meningitis have been reported among Drexel students.

The investigation also revealed that the student had been in close contact with Princeton students about a week before becoming ill.

Drexel University is located in Philadelphia, and Princeton University is in New Jersey.

In response to last year's meningitis outbreak at Princeton, a began on Dec. 9. A large percentage of undergraduate and eligible graduate students received the recommended two doses of the investigational vaccine used for this "B" strain of meningitis. The vaccine is not yet approved in the United States.

However, vaccinated people can still carry the meningitis bacteria in their throats and infect others through close contact, the CDC said.

Because there is no at Drexel, the university community there is not considered to be at increased risk. No vaccination program has been launched, but university officials and the local department of health are taking all the recommended measures to prevent additional cases of , according to the CDC.

"We will continue to closely monitor the situation and determine next steps while local health authorities remain vigilant to recognizing and promptly treating any new cases," the agency said in a news release. "At this time, CDC does not recommend limiting social interactions or canceling travel plans as a preventive measure for meningococcal disease."

The CDC also said there is no evidence that family members and other people are at increased risk of being infected through casual contact with Princeton students, faculty or staff. People at highest risk are those who have close, prolonged or face-to-face contact with an infected person.

"Students at both universities should be especially vigilant to the signs and symptoms of meningococcal disease and seek urgent treatment if suspected," CDC officials said. "Symptoms may include sudden onset of a high fever, headache, stiff neck, nausea, vomiting, rapid breathing or a rash. Hand washing and covering coughs and sneezes are also good practices to follow."

Explore further: Princeton U. to give students meningitis B vaccine (Update 2)

More information: The U.S. Centers for Disease Control and Prevention has more about bacterial meningitis.

Related Stories

Princeton starts mass meningitis B vaccinations (Update 2)

December 9, 2013

Princeton University has begun vaccinating nearly 6,000 students to try to stop an outbreak of type B meningitis in an unusual federal government-endorsed administration of a drug not generally approved for use in the United ...

Princeton vaccine reaches 90 percent of eligible

December 13, 2013

Princeton University officials say more than 90 percent of the eligible students and staff received a meningitis vaccine this week as part of the university's effort to halt an outbreak.

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Arthritis drug may help with type of hair loss

September 22, 2016

(HealthDay)—For people who suffer from a condition that causes disfiguring hair loss, a drug used for rheumatoid arthritis might regrow their hair, a new, small study suggests.

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.